EUCLIDES MARMOLEJOS BAEZ: Open Payments
NPI 1891989232 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 24 payments from 13 companies in 2025. Trend: 2023 $243 · 2024 $347 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $91 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Amgen Inc. | 3 | $56 |
| Corcept Therapeutics | 2 | $50 |
| Exact Sciences Corporation | 2 | $49 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| Lilly USA, LLC | 1 | $24 |
| Novo Nordisk Inc | 1 | $23 |
| Insmed, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
Products named: BREZTRI, Korlym, Cologuard Collection Kit, GARDASIL 9, TRELEGY ELLIPTA, OTEZLA, ZEPBOUND, Rybelsus.
Industry payments across FL — which companies pay providers there.
